Cancer diagnostics firm Agendia has appointed Peter Schineller as its first chief commercial officer.
Schineller’s appointment marks a swift departure from his previous role at Alexza Pharmaceuticals, which he only joined in March 2013 as senior VP and chief commercial officer.
He has additional healthcare experience as general manager at Roche subsidiary Ventana Medical Systems and as senior VP for sales, marketing and commercial operations at Genoptix Medical Laboratories, a diagnostic firm that was acquired by Novartis.
David Macdonald, Agendia’s CEO, explained the creation of the new commercial role: “As we continue our growth momentum into 2013, we are committed to building out a world class organisation capable of managing and growing a much larger company.
“Mr Schineller’s depth of experienced senior leadership of global commercial organisations will help us perpetuate our volume growth, which exceeded 140 percent in 2012.”